Xencor (XNCR) EBIT Margin Growth (3y) (2016 - 2026)
Xencor (XNCR) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -140,443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,443.00 |
| Dec 31, 2025 | 718.00 |
| Sep 30, 2025 | -8,582.00 |
| Jun 30, 2025 | 1,665.00 |
| Mar 31, 2025 | -16,289.00 |
| Dec 31, 2024 | -8,447.00 |
| Sep 30, 2024 | -10,034.00 |
| Jun 30, 2024 | -24,508.00 |
| Mar 31, 2024 | -29,561.00 |
| Dec 31, 2023 | -2,089.00 |
| Sep 30, 2023 | 1,638.00 |
| Jun 30, 2023 | 23,013.00 |
| Mar 31, 2023 | -29,260.00 |
| Dec 31, 2022 | 67,241.00 |
| Sep 30, 2022 | -7,487.00 |
| Jun 30, 2022 | 773.00 |
| Mar 31, 2022 | -3,894.00 |
| Dec 31, 2021 | 24,182.00 |
| Sep 30, 2021 | -21,207.00 |
| Dec 31, 2020 | -5,039.00 |